Pharmaceutical Lobby Sues Trump Administration Over Most-Favored-Nation Pricing

PhRMA filed a lawsuit against the Trump administration to block Medicare drug pricing rules based on international benchmarks. The Most-Favored-Nation model faces legal challenges regarding government authority despite projected savings.